FIM
ASND icon

Freedom Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

Freedom Investment Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,113
Closed -$1.09M – 786
2021
Q4 		$1.09M Buy
8,113
+241
+3% +$35.8K 0.08% 321
2021
Q3 		$1.25M Sell
7,872
-2,174
-22% -$298K 0.1% 274
2021
Q2 		$1.32M Buy
+10,046
New +$1.34M 0.1% 250

Other funds holding ASND

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Freedom Investment Management's ASND Position: Q1 2022 in Review

Freedom Investment Management sold out of Ascendis Pharma A/S (ASND) in Q1 2022, closing a stake of 8,113 shares — an estimated $1.09M sold.

Freedom Investment Management first reported a position in ASND in Q2 2021 and held it in 3 quarters. The position peaked at $1.32M in Q2 2021. 178 funds tracked by Wall St. Rank hold ASND as of Q1 2022.

  • Freedom Investment Management reported no remaining Ascendis Pharma A/S position as of Q1 2022 after selling out during the quarter.
  • Freedom Investment Management sold 8,113 Ascendis Pharma A/S shares in Q1 2022, an estimated $1.09M.
  • Freedom Investment Management first reported a position in Ascendis Pharma A/S in Q2 2021 and held it in 3 quarters.
  • Freedom Investment Management's Ascendis Pharma A/S position peaked at $1.32M in Q2 2021.
  • 178 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2022.

Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.